Long Term Evaluation of Scapular-inserted Contraceptive Implants
Status:
NOT_YET_RECRUITING
Trial end date:
2027-10-01
Target enrollment:
Participant gender:
Summary
This study aims to evaluate long-term outcomes when the etonogestrel contraceptive implant is inserted at an alternative site located over the scapular. The study will evaluate the pharmacokinetics (i.e., drug levels) and side effect profiles of participants who have an etonogestrel contraceptive implant inserted at this alternative scapular site over the course of at least two years.
Phase:
PHASE2
Details
Lead Sponsor:
Yale University
Collaborator:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)